Trump has begun another trade war. Here's a timeline of how we got here
Canada's leader laments lost friendship with US in town that sheltered stranded Americans after 9/11
Chinese EV giant BYD's fourth-quarter profit leaps 73%
You're an American in another land? Prepare to talk about the why and how of Trump 2.0
Chalk talk: Star power, top teams and No. 5 seeds headline the women's March Madness Sweet 16
Purdue returns to Sweet 16 with 76-62 win over McNeese in March Madness
(Reuters) -President-elect Donald Trump met with the chief executives of U.S. drugmakers Pfizer and Eli Lilly as well as industry lobbying group PhRMA on Wednesday night, Axios reported on Thursday.
Anti-vaccine activist Robert F. Kennedy Jr., Trump's pick to lead the United States' top health agency, was also present at the meeting, according to the report.
A PhRMA spokesperson confirmed that its president and CEO, Stephen Ubl, was present at the dinner, but declined to share any other details.
Eli Lilly and Pfizer did not immediately respond to Reuters' requests for comment.
Trump and the company executives discussed how the public and private sectors can collaborate on finding cures for cancer, among other topics, at the meeting, which took place at Mar-a-Lago, according to the report.
Mar-a-Lago is the Florida mansion and private club that Trump calls home.
Trump's incoming chief of staff, Susie Wiles, also attended the meeting, the report added.
(Reporting by Bhanvi Satija and Sriparna Roy in Bengaluru; Editing by Anil D'Silva and Shreya Biswas)
